BioCentury
ARTICLE | Clinical News

Suprep regulatory update

February 11, 2013 8:00 AM UTC

Braintree and partner Ipsen Group (Euronext:IPN; Pink:IPSEY, Boulogne-Billancourt, France) said Eziclen/Izinova was approved under the EU's decentralized procedure for bowel cleansing prior to any pr...